These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 6089311)

  • 1. Acute hemodynamic and hormonal effects of MK-521 in congestive heart failure.
    Dickstein K; Aarsland T; Woie L; Kremer D; Abrahamsen AM
    Scand J Urol Nephrol Suppl; 1984; 79():125-7. PubMed ID: 6089311
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute hemodynamic and hormonal effects of lisinopril (MK-521) in congestive heart failure.
    Dickstein K; Aarsland T; Woie L; Abrahamsen AM; Fyhrquist F; Cummings S; Gomex HJ; Hagen E; Kristianson K
    Am Heart J; 1986 Jul; 112(1):121-9. PubMed ID: 3014850
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute Hemodynamic and Hormonal Effects of Mk-521 in Congestive Heart Failure.
    Dickstein K; Aarsland T; Woie L; Kremer D; Abrahamsen AM
    Scand J Urol Nephrol; 1984 Jul; 18(sup79):125-127. PubMed ID: 27785997
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hemodynamic, hormonal, and pharmacokinetic aspects of treatment with lisinopril in congestive heart failure.
    Dickstein K
    J Cardiovasc Pharmacol; 1987; 9 Suppl 3():S73-81. PubMed ID: 2442558
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of dietary sodium on angiotensin-converting enzyme (ACE) inhibition and the acute hypotensive effect of enalapril (MK-421) in essential hypertension.
    Jackson B; Cubela R; Johnston CI
    J Hypertens; 1984 Aug; 2(4):371-7. PubMed ID: 6099390
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determinants of increased angiotensin II levels in severe chronic heart failure patients despite ACE inhibition.
    van de Wal RM; Plokker HW; Lok DJ; Boomsma F; van der Horst FA; van Veldhuisen DJ; van Gilst WH; Voors AA
    Int J Cardiol; 2006 Jan; 106(3):367-72. PubMed ID: 16337046
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antihypertensive therapy with MK 421: angiotensin II--renin relationships to evaluate efficacy of converting enzyme blockade.
    Biollaz J; Brunner HR; Gavras I; Waeber B; Gavras H
    J Cardiovasc Pharmacol; 1982; 4(6):966-72. PubMed ID: 6185790
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bradykinin contributes to the systemic hemodynamic effects of chronic angiotensin-converting enzyme inhibition in patients with heart failure.
    Cruden NL; Witherow FN; Webb DJ; Fox KA; Newby DE
    Arterioscler Thromb Vasc Biol; 2004 Jun; 24(6):1043-8. PubMed ID: 15105283
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hemodynamic and hormonal effects of quinaprilat in patients with congestive heart failure.
    Mitrovic V; Mudra H; Bonzel T; Schmidt W; Strand JC; Bakovic-Alt R; Posvar EL
    Clin Pharmacol Ther; 1996 Jun; 59(6):686-98. PubMed ID: 8681494
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increase in vasoactive intestinal polypeptides (VIP) by the angiotensin converting enzyme (ACE) inhibitor lisinopril in congestive heart failure. Relation to haemodynamic and hormonal changes.
    Woie L; Dickstein K; Kaada B
    Gen Pharmacol; 1987; 18(6):577-87. PubMed ID: 2822521
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neurohormonal activation in patients with acute myocardial infarction or chronic congestive heart failure. With special reference to treatment with angiotensin converting enzyme inhibitors.
    Sigurdsson A
    Blood Press Suppl; 1995; 1():1-45. PubMed ID: 7599749
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The effect of bunazosin vs captopril on hemodynamic and neurohumoral parameters in patients with congestive heart failure].
    Kawahara Y; Hasegawa K; Sawayama T; Inoue S; Nakamura T; Kakumae S; Tadaoka S; Nakao M; Nezuo S
    Kokyu To Junkan; 1989 Dec; 37(12):1333-40. PubMed ID: 2575781
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative hemodynamic effects of MK-422, a converting enzyme inhibitor, and a renin inhibitor in dogs with acute left ventricular failure.
    Sweet CS; Ludden CT; Frederick CM; Bush LR; Ribeiro LG
    J Cardiovasc Pharmacol; 1984; 6(6):1067-75. PubMed ID: 6084762
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Hemodynamic and humoral effects of parenteral therapy with intravenously administered ACE inhibitor quinaprilat in patients with advanced heart failure].
    Mitrovic V; Mudra H; Bonzel T; Schmidt W; Schlepper M
    Z Kardiol; 1996 Nov; 85(11):828-38. PubMed ID: 9064945
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The influence of ACE inhibitors on urinary electrolyte secretion and the response to transitory hypovolemia in chronic heart failure].
    Marenzi G; Lauri G; Assanelli E; Grazi M; Guazzi M; Berna G; Salvioni A; Agostoni P
    Cardiologia; 1997 Dec; 42(12):1277-83. PubMed ID: 9534323
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overview: the role of angiotensin-converting enzyme inhibitors in cardiovascular therapy.
    Abrams WB; Davies RO; Ferguson RK
    Fed Proc; 1984 Apr; 43(5):1314-21. PubMed ID: 6323221
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlation between angiotensin converting enzyme inhibition and the acute hypotensive response to MK 421 in essential hypertension.
    Jackson B; McGrath BP; Johnston CI
    Clin Exp Pharmacol Physiol Suppl; 1982; 7():99-104. PubMed ID: 6291832
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute haemodynamic, hormonal and electrolyte effects and short-term clinical response to enalapril in heart failure.
    Fitzpatrick D; Nicholls MG; Ikram H; Espiner EA
    J Hypertens Suppl; 1983 Oct; 1(1):147-53. PubMed ID: 6100604
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blood pressure effects of acute intravenous renin or oral angiotensin converting enzyme inhibition in essential hypertension.
    Azizi M; Guyene TT; Chatellier G; Ménard J
    J Hypertens; 1994 Apr; 12(4):419-27. PubMed ID: 8064166
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Neurohumoral activation, regulation of sodium excretion and vasodilator treatment in heart insufficiency].
    Pimenta J; Pereira M; Castro A; Dias P; Azevedo A; Bettencourt P; Ferreira A
    Rev Port Cardiol; 2002 Feb; 21(2):157-62. PubMed ID: 11963285
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.